Plain-English translation of NCT03138941 on ClinicalTrials.gov ↗ ·
This is an observational study that follows patients with systemic lupus erythematosus (SLE) for approximately five years to test whether a treatment goal called Lupus Low Disease Activity State (LLDAS) actually helps prevent long-term organ damage. Researchers will regularly collect information about your disease activity, the treatments you're taking, any damage to your organs, and how lupus affects your quality of life. The goal is to understand whether aiming for and maintaining this low disease activity state truly protects your health over time.
Currently, doctors know that keeping lupus disease activity low is important, but this study aims to prove that reaching and staying at a specific low disease activity level actually prevents organ damage and improves long-term outcomes for patients.
You likely qualify if…
You likely don't qualify if…
You will attend regular clinic visits over about five years where your doctor will collect information about your lupus disease activity and current treatments. Once a year, you'll also complete assessments of organ damage and quality of life using standard questionnaires. There is no investigational medication being tested — this is purely an observational study where researchers track your existing care and health outcomes to see if achieving low disease activity protects against damage.
AI-generated summary from trial data · Jun 14, 2026 · Not medical advice
Australia
China